Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company is currently developing multiple product candidates under its INOpulse® program, a proprietary pulsatile nitric oxide delivery system. Show more

Location: 184 Liberty Corner Rd Ste 302, New Jersey, 07059-6868, US | Website: www.bellerophon.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$0.02

Open

$0.01

Volume

7,027

Day Range

$0.01 - $0.01

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

15.03%

Institutional Own.

8.39%

Qtr Updated

09/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.